Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
about
Binding and killing of bacteria by bismuth subsalicylateHelicobacter pylori: Emergence of a SuperbugCampylobacter pylori and gastroduodenal disease.Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pyloriPrevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitroHelicobacter pylori and peptic ulcers: the present position.Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazineEffect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.In vitro activities of new quinolones against Helicobacter pylori.Susceptibility of Campylobacter pyloridis to 20 antimicrobial agentsHelicobacter pylori detection and antimicrobial susceptibility testing.Local gastric and serum amoxicillin concentrations after different oral application forms.Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents.The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence--a 24 month follow-up study.Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.Helicobacter pylori: a Jordanian studyCampylobacter pyloridis: a new organism to explain an old problem?Helicobacter pylori therapy: effect on peptic ulcer disease.Helicobacter pylori in gastroduodenal disease.Microbiological aspects of Helicobacter pylori (Campylobacter pylori).Evaluation of a new selective medium for Campylobacter pylori.Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori.Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsiaIn vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori)Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Comparison of selective and nonselective media for recovery of Campylobacter pylori from antral biopsies.Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivationSynthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucusComparative sensitivities to antimicrobial agents of Campylobacter pylori and the gastric campylobacter like organism from the ferret.Sensitivity of Campylobacter pylori to colloidal bismuth subcitrate.Structural and solution studies of phenylbismuth(III) sulfonate complexes and their activity against Helicobacter pylori.
P2860
Q24669770-63EDFDC6-5A24-49D6-9728-7C42DDEC0A7AQ27001579-10E95A92-67A1-4C4C-BBC3-81C4EA716B9DQ30667514-C27812FA-3567-4FDA-881F-147830612C7DQ33697989-0046BE66-31D3-4829-B985-6FE1EE9D93C9Q33838835-D8B86C86-AB03-42B7-BC9F-6667AE8BCC6BQ33978620-4371D8F4-9B4A-4DD3-9A86-E0A7B4544CC3Q34375061-48EBEB50-7FB4-4AEB-A0FA-40880964E486Q34379741-EF222591-C642-4CEF-B850-C761D056B5C7Q34529930-749A1295-158D-4335-ADCF-3D1AB5ED9757Q35110775-90F6C51F-CEC8-4379-B5A9-66CE2AFA282DQ35139348-E77E19E7-63A7-4C12-A11E-CB99FFC5B7BFQ35139561-0E110070-584A-4882-A542-590F5423E642Q35653323-06363336-F6EE-4D65-A605-8D314367D64AQ35783436-11FA1DC7-57E3-4BCB-8738-37B3EA00DFA7Q35817181-11DEDD18-E805-41EE-8AE9-54C6F12CE9ABQ35836720-E2352B17-E9A5-42AE-9FAD-95C75BC3F760Q35939006-F6E269B5-0E3E-453B-9175-DC4616E28BEFQ36545248-33C0D52C-4E99-450B-B874-6E64DABB5E9BQ36682244-26D13540-E35B-4892-B6A9-2B620124C4C8Q36721493-2D07313F-8ED6-449E-99F1-41588A5919BCQ37362515-84C15ECE-D360-4B8B-BB1E-808500C4DE71Q37812195-0742F6F9-1A44-43F4-8272-B6A0DE2AA345Q38141754-FD80EA56-84F7-42C8-8DAC-E91EE9E6936BQ38595690-CF929606-E211-4D08-8706-45C236B03531Q39412420-D4F4BC57-4D4E-4157-A512-43217C796499Q39449071-A35B9DB6-B092-4D7B-AA1C-E5217DBDDDB9Q39814822-39176F4C-BC25-4FDD-90D6-7A44CE02ABC2Q39814993-463D1A33-FACD-4056-A53D-BA9451074C1AQ39828752-EC4E0B2E-981D-4F1C-94F7-6437F9A70AE2Q39851436-940FC766-DEBC-459F-8CCE-D690A5F2E125Q40086079-5DCBE529-7D6E-4DDD-94F8-EE76245864EDQ40207976-50660C57-1F51-4B72-AF45-1BB0457F7E0FQ40283869-2C83F92B-9BC2-459A-99F9-6894E55D75A3Q40882735-CBA5E4FB-EC0A-4546-9226-FD5FFBE44534Q41008910-CEB45D12-357E-431A-A2F3-E9593FCDCD9BQ41676173-57FFC6F5-1B94-48E9-BB7D-AA9025B20B7DQ42234267-56ACCFBC-887E-4DB7-A6D4-61B160CF0479Q42841229-FF47848D-E2D8-464F-871B-5D70DACEC835Q42843197-96AE21E3-AF6D-47B0-BF89-C7C5B2E21EFDQ42911373-69F4BF9D-5A8E-4E81-AD46-0286474D397B
P2860
Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@ast
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@en
type
label
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@ast
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@en
prefLabel
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@ast
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@en
P2093
P2860
P356
P1476
Susceptibility of clinical iso ...... is to 11 antimicrobial agents.
@en
P2093
P2860
P304
P356
10.1128/AAC.28.6.837
P407
P577
1985-12-01T00:00:00Z